Iris-fixated posterior chamber intraocular lenses in children

Kimberly G Yen1, Ashvini K Reddy, Mitchell P Weikert

  • 1Department of Ophthalmology and Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas 77030, USA. kgyen@texaschildrenshospital.org

Insights

Iris-fixated posterior chamber intraocular lenses (PCIOL) offer an alternative for pediatric aphakia, but dislocation risks are higher in patients with ectopia lentis. Careful consideration is advised due to potential complications.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Intraocular Lenses

Background:

  • Pediatric aphakia requires effective intraocular lens (IOL) correction.
  • Iris-fixated PCIOLs present an alternative to other suturing techniques.

Purpose of the Study:

  • To evaluate short-term outcomes and complications of iris-fixated PCIOLs in pediatric patients.
  • To compare complication rates in different pediatric populations.

Main Methods:

  • Retrospective, observational case study of 12 pediatric patients (17 eyes).
  • Foldable iris-sutured PCIOLs implanted between 2004 and 2007.
  • Outcome measures included visual acuity changes and complications.

Main Results:

  • Higher dislocation rate (45%) in patients with ectopia lentis (Marfan syndrome, hereditary/idiopathic) compared to other aphakia causes (0%).
  • Mean final visual acuity improved by 0.23 logMAR units.
  • Complications included retinal detachment and iris capture.

Conclusions:

  • Iris-fixated PCIOLs are a viable alternative for pediatric aphakia correction.
  • IOL dislocation is a significant concern, especially in patients with ectopia lentis.
  • Caution is recommended due to potential dislocation and suture degradation.
Abstract

Related Concept Videos

Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...